Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.79 USD | +2.30% | +8.34% | -0.56% |
Apr. 16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
Apr. 11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.56% | 582M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.48% | 22.18B | |
-16.67% | 21.2B | |
-9.68% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- Transcript : AnaptysBio, Inc. - Special Call